Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.
第一作者:
Gilles,Boschetti
第一单位:
INSERM U-1111 CIRI (International Center for Infectiology Research) and University Claude Bernard Lyon 1, Lyon, France; Hospices Civils de Lyon, Department of Gastroenterology, Lyon-Sud Hospital, Pierre-Bénite, France.
作者:
主题词
投药, 口服(Administration, Oral);成年人(Adult);结肠炎, 溃疡性(Colitis, Ulcerative);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);免疫抑制剂(Immunosuppressive Agents);男(雄)性(Male);中年人(Middle Aged);病人遴选(Patient Selection);回顾性研究(Retrospective Studies);疾病严重程度指数(Severity of Illness Index);他罗利姆(Tacrolimus);治疗结果(Treatment Outcome)
DOI
10.1016/j.dld.2014.06.005
PMID
25023007
发布时间
2019-12-10
- 浏览14
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文